Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-12-02

Clinical Trial Update: A Study of Use of Ella®, an Emergency Contraceptive, Under Simulated OTC Conditions [Phase 3]

View source ↗

Summary

Phase 3 trial update for Ella® emergency contraceptive under simulated OTC conditions; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ELLA (ULIPRISTAL ACETATE)

Snippet

Sponsor: HRA Pharma | Conditions: Emergency Contraception | Phase 3 | Status: COMPLETED | Results posted: 2022-12-02